Home › Adenoid Cystic Carcinoma
Adenoid Cystic Carcinoma clinical trials recruiting in the U.S.
9 studies for Adenoid Cystic Carcinoma are recruiting participants at sites across the United States.
Cities with the most studies
By state
- California4 studies
- Florida3 studies
- Massachusetts5 studies
- Michigan3 studies
- New York4 studies
- Texas6 studies
Recently updated studies
Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07162480CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT05774899A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT06891560A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05377996Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 24, 2026 · NCT06118086VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Dec 11, 2025 · NCT03556228A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2025 · NCT06805825Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial
Recruiting
Ages 18 and older · All sexes · Updated Sep 23, 2025 · NCT04883671A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 29, 2025 · NCT06805617From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.